Freenome, Inc. (FRNM)
NASDAQ · Services · Services-medical laboratories
$15.99−$0.0200 (−0.12%) on the dayAs of the close; data may be delayed.
FRNM price, last 12 months
Key stats
- Previous close
- $16.01
- Open
- $15.95
- Day range
- $15.37 – $16.23
- 52-week range
- $9.97 – $17.50
- Volume
- 418.9K
- Avg volume (20 days)
- 1M
- Market cap
- $1.7B
Performance
1W−6.6%
1M+13.5%
3M—
6M—
YTD—
1Y—
Technicals and fundamentals
About Freenome, Inc.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $1.7B